BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18479305)

  • 21. Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia.
    Schierl M; Foedinger D; Geissler K; Rappersberger K; Feldmann R
    Eur J Dermatol; 2008; 18(6):717-8. PubMed ID: 19049939
    [No Abstract]   [Full Text] [Related]  

  • 22. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
    Ahmadi T; Schuster SJ
    J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.
    Foon KA; Boyiadzis M; Land SR; Marks S; Raptis A; Pietragallo L; Meisner D; Laman A; Sulecki M; Butchko A; Schaefer P; Lenzer D; Tarhini A
    J Clin Oncol; 2009 Feb; 27(4):498-503. PubMed ID: 19075274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.
    Bosch F; Abrisqueta P; Villamor N; Terol MJ; González-Barca E; Ferra C; González Diaz M; Abella E; Delgado J; Carbonell F; García Marco JA; Escoda L; Ferrer S; Monzó E; González Y; Estany C; Jarque I; Salamero O; Muntañola A; Montserrat E
    J Clin Oncol; 2009 Sep; 27(27):4578-84. PubMed ID: 19704063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathology of B-cell chronic lymphocytic leukemia.
    Pileri SA; Sabattini E; Agostinelli C; Bodega L; Rossi M; Zinzani PL; Marafioti T
    Hematol Oncol Clin North Am; 2004 Aug; 18(4):807-26, viii. PubMed ID: 15325700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The lymphocytic basophilia after incubation of blood smears in distilled water.
    Smetana K; Lejmar J; Micánková M; Klener P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):701-9. PubMed ID: 2465251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontline therapy for chronic lymphocytic leukemia: the dilemma continues.
    Nabhan C
    Clin Cancer Res; 2008 Jul; 14(13):4353. PubMed ID: 18594019
    [No Abstract]   [Full Text] [Related]  

  • 28. Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population.
    Yang S; Yu Y; Jun-Min L; Jian-Qing M; Qiu-Sheng C; Yu C; Wei-Li Z; Jian-Hua Y; Hui-Jin Z; Yan W; Li W; Shu C; Zhi-Xiang S
    Ann Hematol; 2009 Sep; 88(9):863-9. PubMed ID: 19205655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration.
    Laurenti L; Tarnani M; De Padua L; Efremov DG; Zini G; Garzia M; Piccirillo N; Chiusolo P; Sorà F; Innocenti I; Sica S; Leone G
    Ann Hematol; 2008 Nov; 87(11):891-8. PubMed ID: 18587576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia.
    Forconi F; Fabbri A; Lenoci M; Sozzi E; Gozzetti A; Tassi M; Raspadori D; Lauria F
    Hematol Oncol; 2008 Dec; 26(4):247-51. PubMed ID: 18642397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
    Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
    J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Allogeneic transplantation of the kidney in a patient with B-small cell lymphocytic lymphoma and chronic renal failure].
    Biriukova LS; Dzhumabaeva BT; Daumova VB; Zvonkov EE; Kremenetskaia AM; Kaplanskaia IB; Varlamova EIu; Vorob'ev IA; Gretsov EM; Kravchenko SK; Moseshvili EG; Akhmetshin RB
    Ter Arkh; 2006; 78(10):48-51. PubMed ID: 17180938
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of diffuse large B-cell lymphosarcoma with involvement of bone marrow in an old female patient].
    Zamiatina VI; Kravchenko SK; Giliazitdinova EA; Magomedova AU; Vorob'ev IA; Gotman LN; Kaplanskaia IB; Kesel'man SA; Obukhova TN; Sakhibov IaD; Shevelev AA; Kremenetskaia AM
    Ter Arkh; 2008; 80(7):54-7. PubMed ID: 18763597
    [No Abstract]   [Full Text] [Related]  

  • 34. Progressive trichodysplasia spinulosa in a patient with chronic lymphocytic leukaemia in remission.
    Lee JS; Frederiksen P; Kossard S
    Australas J Dermatol; 2008 Feb; 49(1):57-60. PubMed ID: 18186853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare primary extranodal lymphomas: diffuse large B-cell lymphomas of the genital tract.
    Rajnics P; Demeter J; Csomor J; Krenács L; Pajor L; Kollár B; Kertész Z; Egyed M
    Ann Hematol; 2009 Dec; 88(12):1223-8. PubMed ID: 19352660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent venous thrombosis in a patient with chronic lymphocytic leukemia and acquired protein S deficiency.
    Miljić P; Milosević-Jovicić N; Antunović P; Bosković D; Basara N; Rolović Z
    Haematologia (Budap); 2000; 30(1):51-4. PubMed ID: 10841326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy.
    Posada García C; Florez A; Pardavila R; Garcia-Cruz A; Amador L; Alvarez M; Alberte LM; Cruces MJ
    Eur J Dermatol; 2009; 19(4):394-5. PubMed ID: 19467966
    [No Abstract]   [Full Text] [Related]  

  • 38. Bendamustine in the treatment of chronic lymphocytic leukemia.
    Knauf W
    Expert Rev Anticancer Ther; 2009 Feb; 9(2):165-74. PubMed ID: 19192955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
    Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
    Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab-induced changes in hematolymphoid tissues found at autopsy.
    Cioc AM; Vanderwerf SM; Peterson BA; Robu VG; Forster CL; Pambuccian SE
    Am J Clin Pathol; 2008 Oct; 130(4):604-12. PubMed ID: 18794054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.